PA
CNTB

Perceptive Advisors’s Connect Biopharma Holdings CNTB Stock Holding History

Perceptive Advisors’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Hold
792,696
– – 0.03% 102
2026
Q1 		$2.08M Hold
792,696
– – 0.04% 86
2025
Q4 		$2.24M Buy
+792,696
New +$1.69M 0.04% 104

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Perceptive Advisors's CNTB Position: Q2 2026 in Review

Perceptive Advisors held its Connect Biopharma Holdings (CNTB) position steady in Q2 2026 at 792,696 shares worth $1.89M. The position accounts for 0.03% of the portfolio, ranked #102.

Perceptive Advisors first reported a position in CNTB in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.24M in Q4 2025. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Perceptive Advisors held 792,696 shares of Connect Biopharma Holdings worth $1.89M as of Q2 2026.
  • Perceptive Advisors left its Connect Biopharma Holdings share count unchanged in Q2 2026.
  • Connect Biopharma Holdings made up 0.03% of Perceptive Advisors's portfolio in Q2 2026, its #102 holding.
  • Perceptive Advisors first reported a position in Connect Biopharma Holdings in Q4 2025 and has held it in 3 quarters since.
  • Perceptive Advisors's Connect Biopharma Holdings position peaked at $2.24M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.